Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Global X Genomics & Biotechnology ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Global X Genomics & Biotechnology ETF (GNOM) has returned -3.77% so far this year and 39.46% over the past 12 months.
Global X Genomics & Biotechnology ETF
- 1D
- 5.67%
- 1M
- -8.22%
- YTD
- -3.77%
- 6M
- 14.10%
- 1Y
- 39.46%
- 3Y*
- -3.45%
- 5Y*
- -13.31%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Apr 10, 2019, GNOM's average daily return is 0.00%, while the average monthly return is -0.03%.
Historically, 45% of months were positive and 55% were negative. The best month was Nov 2019 with a return of +18.5%, while the worst month was Jan 2022 at -18.7%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 9 months.
On a daily basis, GNOM closed higher 49% of trading days. The best single day was Apr 9, 2025 with a return of +9.8%, while the worst single day was Mar 12, 2020 at -11.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.91% | -0.05% | -8.22% | -3.77% | |||||||||
| 2025 | 4.84% | -9.33% | -13.87% | 3.02% | -5.13% | 8.60% | 2.86% | 5.92% | 5.70% | 17.00% | 2.08% | -0.74% | 18.65% |
| 2024 | -6.99% | 11.44% | -5.01% | -13.44% | 3.05% | 2.86% | 11.40% | -2.15% | -1.14% | -7.73% | 4.43% | -10.42% | -15.99% |
| 2023 | 7.35% | -7.00% | -2.45% | -0.49% | -0.33% | -0.82% | 1.24% | -8.48% | -9.44% | -12.98% | 17.69% | 10.97% | -8.63% |
| 2022 | -18.69% | -4.21% | -2.78% | -15.24% | -5.81% | 1.83% | 16.53% | -2.88% | -9.26% | 4.78% | 2.66% | -6.30% | -36.27% |
| 2021 | 5.05% | -3.76% | -5.86% | 0.13% | -4.49% | 15.77% | -7.87% | 5.19% | -8.21% | -3.21% | -3.78% | -3.70% | -15.93% |
Benchmark Metrics
Global X Genomics & Biotechnology ETF has an annualized alpha of -12.85%, beta of 1.09, and R² of 0.40 versus S&P 500 Index. Calculated based on daily prices since April 11, 2019.
- This ETF participated in 143.32% of S&P 500 Index downside but only 81.64% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.40 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -12.85%
- Beta
- 1.09
- R²
- 0.40
- Upside Capture
- 81.64%
- Downside Capture
- 143.32%
Expense Ratio
GNOM has an expense ratio of 0.50%, placing it in the medium range.
Return for Risk
Risk / Return Rank
GNOM ranks 66 for risk / return — better than 66% of ETFs on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and compare them to a chosen benchmark (S&P 500 Index).
| GNOM | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.27 | 0.90 | +0.38 |
Sortino ratioReturn per unit of downside risk | 1.87 | 1.39 | +0.48 |
Omega ratioGain probability vs. loss probability | 1.23 | 1.21 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.80 | 1.40 | +0.41 |
Martin ratioReturn relative to average drawdown | 6.02 | 6.61 | -0.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore GNOM risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Global X Genomics & Biotechnology ETF provided a 1.43% dividend yield over the last twelve months, with an annual payout of $0.62 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.62 | $0.62 | $0.00 | $0.00 | $0.00 | $0.03 | $0.13 |
Dividend yield | 1.43% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
Monthly Dividends
The table displays the monthly dividend distributions for Global X Genomics & Biotechnology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 | $0.62 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 | $0.03 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Global X Genomics & Biotechnology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Global X Genomics & Biotechnology ETF was 75.00%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Global X Genomics & Biotechnology ETF drawdown is 60.23%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -75% | Feb 9, 2021 | 1046 | Apr 8, 2025 | — | — | — |
| -35.36% | Dec 26, 2019 | 57 | Mar 18, 2020 | 42 | May 18, 2020 | 99 |
| -21.6% | Apr 11, 2019 | 121 | Oct 2, 2019 | 40 | Nov 27, 2019 | 161 |
| -14.38% | Jul 21, 2020 | 35 | Sep 8, 2020 | 21 | Oct 7, 2020 | 56 |
| -9.15% | Oct 14, 2020 | 13 | Oct 30, 2020 | 8 | Nov 11, 2020 | 21 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...